Evidence map›Paper›PMID 40364408›Full record

ArticlePlants (Basel, Switzerland)2025

Lourdes Inés Pascual, Sebastián Real, Arianna Sosa-Lochedino, Fiorella Campo Verde Arbocco, María Belén Hapon, Carlos Gamarra-Luques

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lourdes Inés PascualInstituto de Medicina y Biología Experimental de Cuyo (IMBECU), Universidad Nacional de Cuyo, CCT Mendoza CONICET, Ruiz Leal s/n, Mendoza 5500, Provincia de Mendoza, Argentina.ORCID 0000-0001-8842-3822
Sebastián RealInstituto de Histología y Embriología de Cuyo (IHEM), Universidad Nacional de Cuyo, CCT Mendoza CONICET, Centro Universitario, Ciudad de Mendoza M5502JJMA, Mendoza, Argentina.ORCID 0000-0001-7286-2724
Arianna Sosa-LochedinoInstituto de Investigaciones en Tecnologías Energéticas y Materiales Avanzados (IITEMA), Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto CP5800, Córdoba, Argentina.ORCID 0000-0002-5338-1412
Fiorella Campo Verde ArboccoInstituto de Medicina y Biología Experimental de Cuyo (IMBECU), Universidad Nacional de Cuyo, CCT Mendoza CONICET, Ruiz Leal s/n, Mendoza 5500, Provincia de Mendoza, Argentina.ORCID 0000-0002-4071-2315
María Belén HaponInstituto de Medicina y Biología Experimental de Cuyo (IMBECU), Universidad Nacional de Cuyo, CCT Mendoza CONICET, Ruiz Leal s/n, Mendoza 5500, Provincia de Mendoza, Argentina.ORCID 0000-0003-4381-5368
Carlos Gamarra-LuquesInstituto de Medicina y Biología Experimental de Cuyo (IMBECU), Universidad Nacional de Cuyo, CCT Mendoza CONICET, Ruiz Leal s/n, Mendoza 5500, Provincia de Mendoza, Argentina.ORCID 0000-0003-1746-9174

Funding

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT-2019-03791 and PICT 2021-Cat II-30SIIP-UNCuyo SIIP-06/J019 and PIO2023-SIIP 80020230100034UN
6 · The paper itself

Abstract

Melanoma is one of the deathliest cancers worldwide and its incidence is reaching epidemic proportions. It is characterized by intrinsic chemo-resistance, low response rates to treatment and high metastatic potential. Because of this, new therapeutic options are permanently required.

Indexed as

antimetastaticantitumoralAsteraceaebotanical compoundscytotoxicity

Identifiers

PMID40364408
PMCPMC12073114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.